Consolidated Statements of Cash Flows - USD ($) $ in Thousands		12 Months Ended
		Dec. 31, 2025		Dec. 31, 2024		Dec. 31, 2023
Operating activities
Net income		$ 161,354		$ 316,978		$ 217,120
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and finance lease amortization		93,328		74,025		62,408
Amortization of intangible assets		101,507		97,743		104,194
Amortization of deferred financing costs and original issue discount		2,380		3,242		3,885
Change in fair value of investments		20,610		38,006		0
Loss on refinancing of debt		1,225	[1]	4,861	[1]	0
Deferred income tax expense (benefit)		15,080		(60,615)		(34,478)
Share-based compensation expense	[2]	49,947		49,248		35,492
Loss (gain) on disposal of assets		(688)		138		(285)
Loss attributable to the disposition of a business		3,905		0		0
Other noncash charges		2,857		5,780		5,922
Excess tax benefits from equity awards		(404)		(5,069)		(977)
Net changes in operating assets and liabilities:
Accounts receivable		45,637		(82,816)		(18,272)
Inventories		(163,117)		122,952		262,670
Other assets		(40,109)		546		24,266
Accounts payable		(40,701)		123,571		(120,900)
Accrued wages and employee benefits		(13,555)		26,870		7,962
Other accrued liabilities		198,722		25,841		(27,337)
Net cash provided by operating activities		437,978		741,301		521,670
Investing activities
Proceeds from sale of property and equipment		3,078		211		2,896
Proceeds from beneficial interest in securitization transactions		0		0		3,294
Contribution to tax equity investment		0		(1,629)		(6,627)
Purchase of long-term investments		(3,035)		(37,821)		(32,592)
Proceeds from sale of long-term investments		0		2,000		0
Expenditures for property and equipment		(169,850)		(136,733)		(129,060)
Acquisition of businesses, net of cash acquired		(762)		(34,740)		(15,974)
Other investing activities		(2,335)		0		0
Net cash used in investing activities		(172,904)		(208,712)		(178,063)
Financing activities
Proceeds from short-term borrowings		36,402		29,219		64,257
Proceeds from long-term borrowings		132,826		541,475		348,827
Repayments of short-term borrowings		(48,211)		(54,548)		(37,104)
Repayments of long-term borrowings and finance lease obligations		(168,503)		(794,600)		(288,699)
Stock repurchases		(147,917)		(152,743)		(251,513)
Payment of debt issuance costs		(5,275)		(3,616)		0
Payment of contingent acquisition consideration		(2,700)		0		(4,979)
Payment of deferred acquisition consideration		(603)		(7,421)		0
Contributions received from noncontrolling interest in subsidiary		979		0		0
Dividends paid to noncontrolling interest of subsidiary		(293)		(273)		0
Purchase of additional ownership interest		0		(9,117)		(104,844)
Taxes paid related to equity awards		(14,284)		(24,769)		(10,897)
Proceeds from the exercise of stock options		4,860		27,558		7,815
Net cash used in financing activities		(212,719)		(448,835)		(277,137)
Net increase in cash and cash equivalents		60,136		80,283		68,271
Cash and cash equivalents at beginning of period		281,277		200,994		132,723
Cash and cash equivalents at end of period		341,413		281,277		200,994
Effect of foreign exchange rate changes on cash and cash equivalents		7,781		(3,471)		1,801
Supplemental disclosure of cash flow information
Interest		75,874		89,420		84,027
Income taxes		$ 89,415		$ 148,828		$ 100,082

[1] For the three and nine months ended September 30, 2025, the loss represents third party costs and the write-off of certain deferred financing costs in connection with the refinancing of the Original Tranche A Term Loan Facility and Original Revolving Facility. For the three and nine months ended September 30, 2024, the loss represents fees paid to creditors and the write-off of the original issue discount and deferred financing costs in connection with the refinancing of the Tranche B Term Loan Facility.

[2] Represents share-based compensation expense to account for stock options, restricted stock, and other stock awards over their respective vesting periods.